CHARLES HORTON: Open Payments
NPI 1114017555 · BERRYVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 11 payments from 8 companies in 2025. Trend: 2023 $148 · 2024 $291 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Gilead Sciences, Inc. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: LEQVIO, Kerendia, Ozempic, XIFAXAN, Cologuard Collection Kit, MOUNJARO, FARXIGA.
Industry payments across AR — which companies pay providers there.
